<p><strong>Kezar Life Sciences 表示，Kevin Tang 在生效时成为存续公司的首席执行官和唯一董事，因为多位现任董事和高管因合并而辞职。</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>个人</strong></td>
<td>John Fowler</td>
<td>Franklin Berger</td>
<td>Graham Cooper</td>
<td>Elizabeth Garner, M.D.</td>
<td>Michael Kauffman, M.D., Ph.D.</td>
<td>Micki Klearman, M.D.</td>
<td>Courtney Wallace</td>
<td>Christopher J. Kirk, Ph.D.</td>
<td>Marc L. Belsky</td>
<td>Mark Schiller</td>
<td>Kevin Tang</td>
<td>Ryan Cole</td>
<td>Michael Hearne</td>
<td>Stephen Robertson</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>高管（离职协议）</td>
<td>高管（离职协议）</td>
<td>高管（离职协议）</td>
<td>首席执行官；唯一董事（合并子公司之前）</td>
<td>首席运营官（合并子公司之前）</td>
<td>首席财务官（合并子公司之前）</td>
<td>首席法律官、公司秘书及首席合规官（合并子公司之前）</td>
</tr>
<tr>
<td><strong>变更类型</strong></td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>在生效时终止（雇佣）</td>
<td>在生效时终止（雇佣）</td>
<td>在生效时终止（雇佣）</td>
<td>在生效时被任命为存续公司的唯一董事和高管</td>
<td>在生效时被任命为存续公司的高管</td>
<td>在生效时被任命为存续公司的高管</td>
<td>在生效时被任命为存续公司的高管</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>签署离职协议；与公司无分歧</td>
<td>签署离职协议；与公司无分歧</td>
<td>签署离职协议；与公司无分歧</td>
<td>根据合并协议（合并子公司成为存续公司）</td>
<td>根据合并协议（合并子公司成为存续公司）</td>
<td>根据合并协议（合并子公司成为存续公司）</td>
<td>根据合并协议（合并子公司成为存续公司）</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>Kevin Tang 在生效时是合并子公司的唯一董事，并成为存续公司的唯一董事/高管</td>
<td>成为存续公司的高管</td>
<td>成为存续公司的高管</td>
<td>成为存续公司的高管</td>
</tr>
<tr>
<td><strong>背景详情</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>签署离职协议（之前于 2026 年 4 月 3 日披露）</td>
<td>签署离职协议（之前于 2026 年 4 月 3 日披露）</td>
<td>签署离职协议（之前于 2026 年 4 月 3 日披露）</td>
<td>在生效时担任合并子公司的唯一董事和首席执行官</td>
<td>在生效时担任合并子公司的首席运营官</td>
<td>在生效时担任合并子公司的首席财务官</td>
<td>在生效时担任合并子公司的首席法律官、公司秘书及首席合规官</td>
</tr>
<tr>
<td><strong>董事会/委员会角色变更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
<p>原始 SEC 文件：Kezar Life Sciences, Inc. [ KZR ] - 8-K -2026 年 5 月 11 日
<strong>免责声明</strong></p>
<p>这是一个由人工智能生成的摘要。可能包含不准确的信息。请考虑与来源核实重要信息。请注意，此摘要仅基于向 SEC 提交的文件。</p>

<p>Kezar Life Sciences 任命 Kevin Tang 为新任首席执行官和唯一董事，此前由于合并多名董事和高管辞职。这些辞职并非由于意见不合，相关人员已签署分离协议。Tang 曾担任合并子公司的唯一董事，将领导存续公司</p>

<p><strong>Kezar Life Sciences said Kevin Tang became Chief Executive Officer and sole director of the surviving company at the Effective Time as multiple current directors and officers resigned in connection with the Merger.</strong></p>
<div class="lb-trans"><p><strong>Kezar Life Sciences 表示，Kevin Tang 在生效时成为存续公司的首席执行官和唯一董事，因为多位现任董事和高管因合并而辞职。</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Individual</strong></td>
<td>John Fowler</td>
<td>Franklin Berger</td>
<td>Graham Cooper</td>
<td>Elizabeth Garner, M.D.</td>
<td>Michael Kauffman, M.D., Ph.D.</td>
<td>Micki Klearman, M.D.</td>
<td>Courtney Wallace</td>
<td>Christopher J. Kirk, Ph.D.</td>
<td>Marc L. Belsky</td>
<td>Mark Schiller</td>
<td>Kevin Tang</td>
<td>Ryan Cole</td>
<td>Michael Hearne</td>
<td>Stephen Robertson</td>
</tr>
<tr>
<td><strong>Role</strong></td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Officer (separation agreement)</td>
<td>Officer (separation agreement)</td>
<td>Officer (separation agreement)</td>
<td>Chief Executive Officer; Sole director (Merger Sub prior)</td>
<td>Chief Operating Officer (Merger Sub prior)</td>
<td>Chief Financial Officer (Merger Sub prior)</td>
<td>Chief Legal Officer, Corporate Secretary and Chief Compliance Officer (Merger Sub prior)</td>
</tr>
<tr>
<td><strong>Type of Change</strong></td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Terminated (employment) at Effective Time</td>
<td>Terminated (employment) at Effective Time</td>
<td>Terminated (employment) at Effective Time</td>
<td>Appointed as sole director and officer of Surviving Corporation at Effective Time</td>
<td>Appointed as officer of Surviving Corporation at Effective Time</td>
<td>Appointed as officer of Surviving Corporation at Effective Time</td>
<td>Appointed as officer of Surviving Corporation at Effective Time</td>
</tr>
<tr>
<td><strong>Effective Date</strong></td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
</tr>
<tr>
<td><strong>Reason</strong></td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Entered into separation agreement; no disagreements with the Company</td>
<td>Entered into separation agreement; no disagreements with the Company</td>
<td>Entered into separation agreement; no disagreements with the Company</td>
<td>Per Merger Agreement (Merger Sub became Surviving Corporation)</td>
<td>Per Merger Agreement (Merger Sub became Surviving Corporation)</td>
<td>Per Merger Agreement (Merger Sub became Surviving Corporation)</td>
<td>Per Merger Agreement (Merger Sub became Surviving Corporation)</td>
</tr>
<tr>
<td><strong>Replacement Info</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Kevin Tang was sole director of Merger Sub prior to Effective Time and became sole director/officer of Surviving Corporation</td>
<td>Became officer of Surviving Corporation</td>
<td>Became officer of Surviving Corporation</td>
<td>Became officer of Surviving Corporation</td>
</tr>
<tr>
<td><strong>Background Details</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Entered separation agreement (previously disclosed Apr 3, 2026)</td>
<td>Entered separation agreement (previously disclosed Apr 3, 2026)</td>
<td>Entered separation agreement (previously disclosed Apr 3, 2026)</td>
<td>Served as sole director and CEO of Merger Sub immediately prior to Effective Time</td>
<td>Served as COO of Merger Sub immediately prior to Effective Time</td>
<td>Served as CFO of Merger Sub immediately prior to Effective Time</td>
<td>Served as Chief Legal Officer, Corporate Secretary and Chief Compliance Officer of Merger Sub immediately prior to Effective Time</td>
</tr>
<tr>
<td><strong>Board/Committee Role Changes</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>个人</strong></td>
<td>John Fowler</td>
<td>Franklin Berger</td>
<td>Graham Cooper</td>
<td>Elizabeth Garner, M.D.</td>
<td>Michael Kauffman, M.D., Ph.D.</td>
<td>Micki Klearman, M.D.</td>
<td>Courtney Wallace</td>
<td>Christopher J. Kirk, Ph.D.</td>
<td>Marc L. Belsky</td>
<td>Mark Schiller</td>
<td>Kevin Tang</td>
<td>Ryan Cole</td>
<td>Michael Hearne</td>
<td>Stephen Robertson</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>高管（离职协议）</td>
<td>高管（离职协议）</td>
<td>高管（离职协议）</td>
<td>首席执行官；唯一董事（合并子公司之前）</td>
<td>首席运营官（合并子公司之前）</td>
<td>首席财务官（合并子公司之前）</td>
<td>首席法律官、公司秘书及首席合规官（合并子公司之前）</td>
</tr>
<tr>
<td><strong>变更类型</strong></td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>辞职</td>
<td>在生效时终止（雇佣）</td>
<td>在生效时终止（雇佣）</td>
<td>在生效时终止（雇佣）</td>
<td>在生效时被任命为存续公司的唯一董事和高管</td>
<td>在生效时被任命为存续公司的高管</td>
<td>在生效时被任命为存续公司的高管</td>
<td>在生效时被任命为存续公司的高管</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
<td>在生效时</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>因合并辞职；并非因分歧</td>
<td>签署离职协议；与公司无分歧</td>
<td>签署离职协议；与公司无分歧</td>
<td>签署离职协议；与公司无分歧</td>
<td>根据合并协议（合并子公司成为存续公司）</td>
<td>根据合并协议（合并子公司成为存续公司）</td>
<td>根据合并协议（合并子公司成为存续公司）</td>
<td>根据合并协议（合并子公司成为存续公司）</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>Kevin Tang 在生效时是合并子公司的唯一董事，并成为存续公司的唯一董事/高管</td>
<td>成为存续公司的高管</td>
<td>成为存续公司的高管</td>
<td>成为存续公司的高管</td>
</tr>
<tr>
<td><strong>背景详情</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>签署离职协议（之前于 2026 年 4 月 3 日披露）</td>
<td>签署离职协议（之前于 2026 年 4 月 3 日披露）</td>
<td>签署离职协议（之前于 2026 年 4 月 3 日披露）</td>
<td>在生效时担任合并子公司的唯一董事和首席执行官</td>
<td>在生效时担任合并子公司的首席运营官</td>
<td>在生效时担任合并子公司的首席财务官</td>
<td>在生效时担任合并子公司的首席法律官、公司秘书及首席合规官</td>
</tr>
<tr>
<td><strong>董事会/委员会角色变更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
</div><p>Original SEC Filing: Kezar Life Sciences, Inc. [ KZR ] - 8-K - May. 11, 2026
<strong>Disclaimer</strong></p>
<div class="lb-trans"><p>原始 SEC 文件：Kezar Life Sciences, Inc. [ KZR ] - 8-K -2026 年 5 月 11 日
<strong>免责声明</strong></p>
</div><p>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</p>
<div class="lb-trans"><p>这是一个由人工智能生成的摘要。可能包含不准确的信息。请考虑与来源核实重要信息。请注意，此摘要仅基于向 SEC 提交的文件。</p>
</div>

Kevin Tang 被任命为 Kezar Life Sciences 的首席执行官，同时多位董事和高管辞职